Clinical review on triglycerides

U Laufs, KG Parhofer, HN Ginsberg… - European heart …, 2020 - academic.oup.com
Hypertriglyceridaemia is a common clinical problem. Epidemiologic and genetic studies
have established that triglyceride-rich lipoproteins (TRL) and their remnants as important …

Systems biology in cardiovascular disease: a multiomics approach

A Joshi, M Rienks, K Theofilatos, M Mayr - Nature Reviews Cardiology, 2021 - nature.com
Omics techniques generate large, multidimensional data that are amenable to analysis by
new informatics approaches alongside conventional statistical methods. Systems theories …

Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke

MV Holmes, IY Millwood, C Kartsonaki, MR Hill… - Journal of The American …, 2018 - jacc.org
Background: Blood lipids are established risk factors for myocardial infarction (MI), but
uncertainty persists about the relevance of lipids, lipoprotein particles, and circulating …

[HTML][HTML] The role of lipids and lipoproteins in atherosclerosis

MRF Linton, PG Yancey, SS Davies, WG Jerome… - Endotext …, 2019 - ncbi.nlm.nih.gov
Atherosclerosis is the underlying cause of heart attack and stroke. Early observations that
cholesterol is a key component of arterial plaques gave rise to the cholesterol hypothesis for …

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction

NS Nurmohamed, JM Kraaijenhof, M Mayr… - European heart …, 2023 - academic.oup.com
Given the limited accuracy of clinically used risk scores such as the Systematic COronary
Risk Evaluation 2 system and the Second Manifestations of ARTerial disease 2 risk scores …

Lipid management in patients with chronic kidney disease

CJ Ferro, PB Mark, M Kanbay, P Sarafidis… - Nature Reviews …, 2018 - nature.com
An increased risk of cardiovascular disease, independent of conventional risk factors, is
present even at minor levels of renal impairment and is highest in patients with end-stage …

Remnants of the triglyceride-rich lipoproteins, diabetes, and cardiovascular disease

A Chait, HN Ginsberg, T Vaisar, JW Heinecke… - Diabetes, 2020 - diabetesjournals.org
Diabetes is now a pandemic disease. Moreover, a large number of people with prediabetes
are at risk for develo** frank diabetes worldwide. Both type 1 and type 2 diabetes increase …

Quantifying atherogenic lipoproteins: current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol. A consensus …

MR Langlois, MJ Chapman, C Cobbaert… - Clinical …, 2018 - academic.oup.com
Abstract BACKGROUND The European Atherosclerosis Society–European Federation of
Clinical Chemistry and Laboratory Medicine Consensus Panel aims to provide …

Lipid-lowering agents: targets beyond PCSK9

RA Hegele, S Tsimikas - Circulation research, 2019 - ahajournals.org
Several new or emerging drugs for dyslipidemia owe their existence, in part, to human
genetic evidence, such as observations in families with rare genetic disorders or in …

Efficacy and safety of mipomersen: a systematic review and meta-analysis of randomized clinical trials

F Fogacci, N Ferri, PP Toth, M Ruscica, A Corsini… - Drugs, 2019 - Springer
Aim Our aim was to assess the efficacy and safety of mipomersen through a systematic
review of the literature and a meta-analysis of the available clinical studies. Methods A …